DMTRF (DMTRF) Stock Price & Analysis
DMTRF (DMTRF) rose 0.00% to USD 2.25 as of June 10, 2026 at 02:27 UTC, according to Nexqual real-time market data.
DMTRF last closed at USD 2.25; the session ranged USD 1.11–1.11 on volume of 5,000 shares. Market capitalization is $270.48M, with a 52-week range of USD 0.69–3.96 (PNK). Source: Nexqual, June 10, 2026 at 02:27 UTC.
Key Statistics (as of June 10, 2026 at 02:27 UTC)
| Price | USD 2.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.25 |
| Open | USD 1.11 |
| Day Range | USD 1.11 – 1.11 |
| 52-Week Range | USD 0.69 – 3.96 |
| Volume | 5,000 shares |
| Market Cap | $270.48M |
| Exchange | PNK |
Technical Analysis (DMTRF)
Nexqual's technical model rates DMTRF "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 3.62) |
| MACD | -0.46 (negative) |
Analyst Ratings (DMTRF)
Wall Street analysts rate DMTRF "None", per Nexqual as of June 10, 2026 at 02:27 UTC.
| Consensus Rating | None |
|---|
Earnings (DMTRF)
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Financials & Fundamentals (DMTRF)
| Total Revenue | $9.22B |
|---|---|
| Revenue Growth (YoY) | +42.20% |
| Gross Margin | +70.56% |
| Operating Margin | +13.71% |
| Profit Margin | +13.51% |
| ROE | +31.86% |
| Debt / Equity | 11.1 |
| Current Ratio | 3.63 |
| Total Cash | $2.10B |
| Total Debt | $575.00M |
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Financial Health Score (DMTRF)
Nexqual rates DMTRF's overall financial health "Strong" across five dimensions, as of June 10, 2026 at 02:27 UTC.
| Growth | Strong — Revenue +259% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 71%, operating 14% |
| Balance Sheet | Strong — $2.10B cash vs $575M debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Strong — ROE 32%, ROA 1.4% |
Ownership (DMTRF)
| Insider Ownership | +7.41% |
|---|---|
| Institutional Ownership | +7.35% |
| Shares Outstanding | 120.21M |
| Float | 115.89M |
Source: Nexqual, June 10, 2026 at 02:27 UTC.
Leadership (DMTRF)
DMTRF is led by Keiji Nagano (age 71), Executive Chairman of the Board, per Nexqual as of June 10, 2026 at 02:27 UTC.
| Executive Chairman of the Board | Keiji Nagano (age 71) |
|---|---|
| Representative Director, President & Director | Toshi Amanuma (age 50) |
| Executive Officer, Head of Business Development & Director | Satoru Kobayashi (age 45) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNBIF | SANBIO COMPANY LIMITED | USD 16.45 | ▲ 0% |
| PYNKF | Perimeter Medical Imaging AI, I | USD 0.21 | ▼ 4.55% |
| DNACF | Dena Co., Ltd. | USD 16.95 | ▲ 6.94% |
| CYBQY | Cyberdyne Inc. | USD 2.16 | ▲ 0% |
| LTGHY | Life Healthcare Group Holdings | USD 2.38 | ▼ 2.46% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:27 UTC. This page is informational and not investment advice.